Welcome to the New Drugwonks.com http://drugwonks.com/index DrugWonks.com | Debating Today's Drugs Policies en-us Thu, 06 Sep 2007 10:55:48 -0400 Sat, 03 Aug 2013 12:20:34 -0400 http://blogs.law.harvard.edu/tech/rss Psyclone WMS 4.4.9 info@drugwonks.com (drugwonks) cpernice@psycloneinc.com (Christopher Pernice) Opioids Auth-orization http://drugwonks.com/blog/opioids-auth-orization To paraphrase Peter Drucker, the information revolution will shift -- from the generation of data, to figuring out the meaning and purpose of the data with the patient’s perspective in mind. Welcome to the world of opioid REMS. Thu, 05 May 2016 07:18:54 -0400 http://drugwonks.com/blog/opioids-auth-orization Confirmation Bias Distorts Drug Price Research and Reporting http://drugwonks.com/blog/confirmation-bias-distorts-drug-price-research-and-reporting Tue, 03 May 2016 17:43:45 -0400 http://drugwonks.com/blog/confirmation-bias-distorts-drug-price-research-and-reporting Getting Real World About Outcomes Data http://drugwonks.com/blog/getting-real-world-about-outcomes-data A health technology assessment model for the 21st Century should reflect and measure individual response to treatment based on the combination of genetic, clinical, and demographic factors that indicate what keep people healthy, improve their health, and prevent disease. A rapidly aging society demands a new healthcare paradigm capable of providing for its needs in the 21st Century. Equality of care must be matched with quality of care. Fri, 29 Apr 2016 08:40:00 -0400 http://drugwonks.com/blog/getting-real-world-about-outcomes-data Buffalo Wings http://drugwonks.com/blog/buffalo-wings Keeping the feds out of price negotiations between private insurers and drug companies has worked wonders. Surveys indicate nine out of 10 seniors are satisfied with their Part D coverage; 96 percent report that their coverage works well. And because insurers have a financial incentive to attract enrollees by keeping plans affordable, the program cost $349 billion less than initially projected during its first decade. Thu, 28 Apr 2016 10:50:53 -0400 http://drugwonks.com/blog/buffalo-wings PBM and Insurer Funded Front Group Demands Bigger Rebates and Less Medical Innovation http://drugwonks.com/blog/pbm-and-insurer-funded-front-group-demands-bigger-rebates-and-less-medical-innovation The Coalition for Sustainable Drug Priceing is a payor funded grab for control over the development, pricing and access of medicines Mon, 25 Apr 2016 10:39:28 -0400 http://drugwonks.com/blog/pbm-and-insurer-funded-front-group-demands-bigger-rebates-and-less-medical-innovation TheStreet.com's Feurstein Fast and Loose With Remicade Pricing Truth http://drugwonks.com/blog/thestreet-com-s-feurstein-fast-and-loose-with-pricing-facts There is a reason we ask for the whole truth. Wed, 20 Apr 2016 15:52:42 -0400 http://drugwonks.com/blog/thestreet-com-s-feurstein-fast-and-loose-with-pricing-facts Wither "Cures?" http://drugwonks.com/blog/wither-cures Is the cure worse than the disease? A thoughtful and comprehensive overview in BioCentury (by one of our favorite industry cognoscenti, Steve Usdin), Can “Cures” be Cured, presents a blunt appraisal for either measured optimism or realpolitk pessimism. Mon, 18 Apr 2016 10:01:30 -0400 http://drugwonks.com/blog/wither-cures Most of the Increase in Drug Spending Pocketed By PBMs and Insurers http://drugwonks.com/blog/most-of-the-increase-in-drug-spending-pocketed-by-pbms-and-insurers Fri, 15 Apr 2016 15:19:13 -0400 http://drugwonks.com/blog/most-of-the-increase-in-drug-spending-pocketed-by-pbms-and-insurers Transparency isn't a one-way proposition http://drugwonks.com/blog/transparency-isn-t-a-one-way-proposition Transparency in medicine isn't a one-way street. The transparent truth is that the prices patients actually pay aren't set by drug manufacturers — they're determined by pharmacy benefit managers, insurers, hospitals and pharmacies. Sun, 10 Apr 2016 20:27:48 -0400 http://drugwonks.com/blog/transparency-isn-t-a-one-way-proposition In support of Pharma Pros -- not Pharma Bros http://drugwonks.com/blog/in-support-of-pharma-pros-not-pharma-bros There’s a torch and pitchfork sale underway in the nation’s capital — or so it would seem from Congress’ recent witch hunt targeting the pharmaceutical industry. Fri, 08 Apr 2016 11:36:15 -0400 http://drugwonks.com/blog/in-support-of-pharma-pros-not-pharma-bros ICER Multiple Myeloma Cherry-picking Update: More People Killed http://drugwonks.com/blog/icer-multiple-myeloma-cherry-picking-update-more-people-killed Fri, 08 Apr 2016 10:02:15 -0400 http://drugwonks.com/blog/icer-multiple-myeloma-cherry-picking-update-more-people-killed Alexander's 21st Century Cures Band http://drugwonks.com/blog/alexander-s-21st-century-cures-band According to a BioCentury report about yesterday’s Senate Health, Education, Labor and Pensions Committee (HELP) hearing on biomedical innovation legislation, Chairman Lamar Alexander (R-TN.) said he plans to bring companion legislation for the 21st Century Cures Act (H.R. 6) to the Senate floor if he can obtain bipartisan agreement on mandatory "surge" funding for NIH. Sen. Patty Murray (D-WA.), the committee's ranking member, said Democratic support for innovation legislation is contingent on mandatory funding increases for both NIH and FDA Thu, 07 Apr 2016 06:51:37 -0400 http://drugwonks.com/blog/alexander-s-21st-century-cures-band Amgen's Right, ICER Cherry Picks Who Lives Or Dies http://drugwonks.com/blog/icer-cherry-picking Wed, 06 Apr 2016 22:46:23 -0400 http://drugwonks.com/blog/icer-cherry-picking How PBMs and Insurers Profit By Discriminating Against 4 Percent of Americans http://drugwonks.com/blog/how-pbms-and-insurers-profit-by-discriminating-against-4-percent-of-americans Some think discrimination is progress. Wed, 06 Apr 2016 17:11:21 -0400 http://drugwonks.com/blog/how-pbms-and-insurers-profit-by-discriminating-against-4-percent-of-americans Facts About Cancer Costs: Orphaned and Ignored http://drugwonks.com/blog/facts-about-cancer-costs-orphaned-and-ignored Facts are stubborn things, even when they are ignored Tue, 05 Apr 2016 17:05:07 -0400 http://drugwonks.com/blog/facts-about-cancer-costs-orphaned-and-ignored Malpractice Prescriptions http://drugwonks.com/blog/malpractice-prescriptions When it comes to medical malpractice, silence and surprise are the enemy of mutual respect and understanding. Mon, 04 Apr 2016 12:23:31 -0400 http://drugwonks.com/blog/malpractice-prescriptions ICER Unveils New Value-Based Drug Pricing That Includes Additional Cost of Living Longer http://drugwonks.com/blog/icer-unveils-new-value-based-drug-pricing-that-includes-additional-cost-of-living-longer Just when you thought it couldn't get any worse... Fri, 01 Apr 2016 10:15:31 -0400 http://drugwonks.com/blog/icer-unveils-new-value-based-drug-pricing-that-includes-additional-cost-of-living-longer At long last (biosimilar) labeling http://drugwonks.com/blog/at-long-last-biosimilar-labeling After much anticipation the FDA has issued draft guidance on Labeling for Biosimilar Products. In two words, no surprises – which for some is better news than for others. Thu, 31 Mar 2016 13:54:19 -0400 http://drugwonks.com/blog/at-long-last-biosimilar-labeling The Abuse Deterrent Opioid Ecosystem http://drugwonks.com/blog/the-abuse-deterrent-opioid-ecosystem I've said it before and I'll say it again, addressing opioid abuse and addiction isn't just a formulation problem ... it's a systems problem. Consider Utah Attorney General Sean Reyes' op-ed on opioid abuse (A smart way to counter prescription drug deaths). There are a few things that need to be added – and amended. Tue, 22 Mar 2016 10:18:58 -0400 http://drugwonks.com/blog/the-abuse-deterrent-opioid-ecosystem Proto thoughts on 21st Century Cures http://drugwonks.com/blog/proto-thoughts-on-21st-century-cures IN JULY 2015, the United States House of Representatives approved the 21st Century Cures Act with broad bipartisan support. The legislation, which aims to “save more lives and keep this country the leader in medical innovation,” provides $8.75 billion in funding for the National Institutes of Health and accelerates approval processes for drugs and medical devices. But as the bill heads to the Senate for approval, critics argue that pharmaceutical and biotechnology interest groups will benefit at the expense of patient safety. Mon, 21 Mar 2016 09:49:02 -0400 http://drugwonks.com/blog/proto-thoughts-on-21st-century-cures